PROGEN — Prostatype Genomics AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK6.09m
- -SEK4.94m
- SEK0.68m
Annual cashflow statement for Prostatype Genomics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2018 June 30th | 2019 June 30th | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 18 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Interim Report | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.32 | -8.55 | -17.4 | -15.6 | -29.1 |
| Non-Cash Items | 0.195 | 0.713 | 0.776 | 0.088 | 1.9 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.41 | -1.8 | 1.92 | -0.537 | -0.511 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -5.71 | -9.63 | -14.7 | -16.1 | -27.7 |
| Capital Expenditures | -4.66 | -3.26 | -3.26 | -2.5 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -4.66 | -3.26 | -3.26 | -2.5 | 0 |
| Financing Cash Flow Items | 0 | 0 | 27.9 | 23.2 | 19.3 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 8.1 | 7.38 | 31.1 | 23 | 18.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.27 | -5.52 | 13.2 | 4.47 | -8.84 |